Pankaj Agrawal – Wondrx | Connecting Healthcare – Connecting Lives
View Detailed Executive Profile →Professional Overview
- Pankaj Agrawal is a co-founder and director at WONDRx, an organization aimed at connecting healthcare with personal health journeys, established in September 2019.
- In May 2023, Pankaj Agrawal transitioned to a role as a member of the board of directors at WONDRx, enhancing governance and strategic direction.
- Prior to founding WONDRx, Pankaj Agrawal held significant roles at UCB, including Head of Ecosystem and Market Access from April 2018 to August 2019, which focused on strategic access to healthcare markets.
- Pankaj Agrawal served as Head of Sales, Pricing, and Access at UCB from May 2016 to March 2018, contributing to sales leadership and market strategies.
- From August 2015 to April 2016, Pankaj Agrawal was the National Sales Manager and SFE Lead for the Multiple Sclerosis Business Unit at UCB, where strategic sales initiatives were a key focus.
- Prior roles at Biogen included National Sales Manager and Sales Force Excellence Lead for India from August 2011 to July 2015, which involved overseeing sales management and team excellence strategies.
- Pankaj Agrawal gained experience as Deputy General Manager at Eli Lilly India from April 2010 to March 2011, leading a team focused on bone health and growth.
- The career at AstraZeneca India began in May 2004, progressing through multiple roles such as Zonal Business Manager in Oncology and Zonal Training Manager, reflecting a strong background in sales and training.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| AstraZeneca India | Zonal Training Manager- (West) | Oct 2004 – Dec 2005 |
| UCB | Head- Sales, Pricing and Access | May 2016 – Mar 2018 |
| Eli Lilly India (Pvt) Ltd. | Sr.Business Manager (West) -Bone Health & Growth Team | May 2009 – Mar 2010 |
| AstraZeneca India | Zonal Business Manager- Oncology (West) | May 2008 – Apr 2009 |
| AstraZeneca India | Assistant Manager- Training | May 2004 – Oct 2004 |
| AstraZeneca India | TBM/ PSR | Jun 1999 – Apr 2004 |
| AstraZeneca India | Area Business Manager - Critical Care | Jan 2006 – May 2008 |
| UCB | National Sales Manager and SFE Lead (Multiple Sclerosis BU) | Aug 2015 – Apr 2016 |
| Biogen | National Sales Manager and Sales Force Excellence Lead India. | Aug 2011 – Jul 2015 |
| UCB | Head- Ecosystem and Market Access | Apr 2018 – Aug 2019 |
| Eli Lilly India (Pvt) Ltd. | Deputy General Manager- Bone Health And Growth Team | Apr 2010 – Mar 2011 |
| WONDRx | Connecting Healthcare – Connecting Lives | Co-Founder & Director | Sep 2019 – Present |
| WONDRx | Innovation for Better | Member Board of Directors | May 2023 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Wondrx | Connecting Healthcare – Connecting Lives corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Pankaj Agrawal's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Wondrx | Connecting Healthcare – Connecting Lives's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)